Christopher E. Rudd

2300 Blvd Alfred Nobel
Montreal, QC H4S2A4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

CD4/CD8-p56lck Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy.

CD4/CD8-p56lck Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy.

Journal: Biomolecules

Published: June 15, 2025

Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity.

Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity.

Journal: Science advances

Published: May 23, 2025

GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

Journal: Signal transduction and targeted therapy

Published: May 08, 2025

GSK-3 regulates CD4-CD8 cooperation needed to generate super-armed CD8+ cytolytic T cells against tumors.

GSK-3 regulates CD4-CD8 cooperation needed to generate super-armed CD8+ cytolytic T cells against tumors.

Journal: bioRxiv : the preprint server for biology

Published: March 31, 2025

Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.

Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.

Journal: Cellular & molecular immunology

Published: January 27, 2025

The identification of a SARs-CoV2 S2 protein-derived peptide with super-antigen-like stimulatory properties on T-cells.

The identification of a SARs-CoV2 S2 protein-derived peptide with super-antigen-like stimulatory properties on T-cells.

Journal: bioRxiv : the preprint server for biology

Published: December 09, 2024

Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy.

Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: November 18, 2024

The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy.

The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy.

Journal: Journal of cancer biology

Published: May 30, 2024

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Journal: The Journal of clinical investigation

Published: May 01, 2024

Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Journal: Nature

Published: February 09, 2024

PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity.

PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity.

Journal: Cell reports

Published: October 03, 2023

Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.

Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.

Journal: Communications biology

Published: September 19, 2023

Showing 1-12 of 72

Last Updated: 09/26/2026